Levi & Korsinsky Reminds Merck & Co., Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK
Portfolio Pulse from
Levi & Korsinsky law firm is pursuing a class action securities lawsuit against Merck & Co., alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 28, 2025 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck's stock price could face continued pressure from the class action lawsuit alleging securities fraud related to Gardasil sales projections in China.
The lawsuit directly targets Merck's representations about Gardasil sales, which caused a significant stock price drop. The legal action and potential financial penalties could negatively impact investor sentiment and stock performance.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100